How do I interpret an LDL-C trend across three draws?

My laboratory results are from the same laboratory each time, drawn fasting, which I gather matters.

I have read the primary source rather than the summary, which has left me with more questions.

I understand the headline. I do not understand the footnotes, and the footnotes look important.

What can I legitimately conclude from this figure?

Answering this needs to distinguish screening from monitoring. A screening panel looks for the unexpected; a monitoring panel tracks something you already have a reason to watch.

Same laboratory, same method, same time of day, same fasting state. Between-laboratory differences on several common analytes are larger than the changes people are trying to detect.

Keep the reports rather than the numbers. Units, reference intervals and methods all vary, and a bare number two years later is not comparable to anything.

Pre-analytical factors — posture, tourniquet time, fasting, sample handling — are the largest source of error in routine biochemistry, well ahead of the analysis itself.

Keep the full report, not the number. You will need the units and the interval later.

Start with a baseline. A result taken before anything started converts most later ambiguity into a simple comparison, and it cannot be obtained retrospectively.

Repeat before you react. A single abnormal value has a substantial probability of being within the combined biological and analytical variation of a normal one.

A twenty-analyte panel run on a healthy person will produce, on average, one out-of-range result purely from how reference intervals are constructed. That is arithmetic rather than pathology.

Nothing here is medical advice. If something is out of range and you do not know why, that is a consultation rather than a research project.

Decide the action for each result before you order the test.

Before reacting to any single value, check whether it is outside the interval by an amount larger than the assay's own variation.

Haemolysis in the sample raises potassium and several enzymes spuriously. If a result is bizarre, ask whether the sample was flagged before building a theory on it.

Biological variation data are published per analyte and are the basis for the reference change value — the difference between two results that is larger than noise.

Research-use compounds are not approved for human use, and no panel makes that safer.

Baseline first, then a repeat under identical conditions. Everything else is secondary.

edited 3 Sept 2025 by fib4_reader — added the citation requested in comments

The honest position is that most people order too many analytes and too few time points, when the reverse would be more informative.

A sensible core for this population is a full blood count, renal function with electrolytes, liver enzymes with bilirubin, a fasting lipid panel with apolipoprotein B, HbA1c and thyroid-stimulating hormone.

The caveat is that a panel is not a diagnosis and interpreting one is a clinician's job, particularly when several values move together.

One out-of-range value on a twenty-analyte panel is expected. Two on a repeat is a finding.